Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001472161-13-000001
Filing Date
2013-01-03
Accepted
2013-01-03 15:09:48
Documents
1
Period of Report
2013-01-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4126
  Complete submission text file 0001472161-13-000001.txt   5483
Mailing Address 1420 5TH AVE SUITE 2600 SEATTLE WA 98101
Business Address 1420 5TH AVE SUITE 2600 SEATTLE WA 98101 206-676-5000
OMEROS CORP (Issuer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1420 FIFTH AVENUE SUITE 2600 SEATTLE WA 98101-2347
Business Address
Demopulos Peter A MD (Reporting) CIK: 0001472161 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34475 | Film No.: 13506135